Activating transcription factor 3 (ATF3) made GC cells sensitive to cisplatin by blocking NRF2/KEAP1/XCT pathway transduction and inducing ferroptosis, which provides a promising treatment for overcoming the chemoresistance of GC (Fu et al., 2021). This evidence concerns the gene ATF3 and gastric cancer.